News & Articles

Here’s what you should know when choosing the best bottles for your cell culture experiment

The assay is developed for use in detection, characterisation, and monitoring of the SARS-CoV-2 virus

Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection

Two different dosing regimens demonstrated efficacy with one showing a better profile

LC 300 platform and SimplicityChrom software offers improved workflows, intuitive user interface and 21 CFR Part 11 compliance

The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic

Observations of rapid recovery on chest x-rays noted and no drug-related Serious Adverse Events reported

The new lots further enhance Lonza’s renowned human primary cell offerings as it looks to meet growing market demand for deeper cell characterization

Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing

QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes

Phase 3 part of clinical trial to enrol over 30,000 volunteers worldwide

Collaboration to develop next-generation CAR-T cell therapies with improved efficacy and durability

The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR

Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and vaccine development

Study by University of Manchester reassures patients that it is safe to take blood pressure medication during the pandemic

New kit aims to provide highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s

Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies

Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days

The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts

The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens

Watch this on-demand webinar to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry

The partnership aims to expand existing Monocyte Distribution Width (MDW) hematology-based biomarker to potentially aid in the rapid detection of MIS-C